# AnticoagEvaluator vs Anticoagulation Manager

AnticoagEvaluator and Anticoagulation Manager both sit at 2.3 stars, but that hides the real split: 50% of Anticoagulation Manager's written reviews are positive against 30% of AnticoagEvaluator's. On price, rating, ratings volume and update cadence there is nothing between them.

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

On the App Store both sit at effectively the same score — 2.3 for AnticoagEvaluator against 2.3 for Anticoagulation Manager. Both are backed by a comparable volume of ratings — 3 and 4 respectively. Written reviews are what separate them: 30% of AnticoagEvaluator's written reviews are positive against 50% of Anticoagulation Manager's.

AnticoagEvaluator ships an update every 7 months, Anticoagulation Manager every 13 months. Both last shipped on November 5, 2026.

## The numbers

| Metric | AnticoagEvaluator | Anticoagulation Manager |
| --- | --- | --- |
| Price | Free | Free |
| Rating | **[2.3 (3 ratings)](https://appshunter.io/ios/app/anticoagevaluator/id609795286/reviews)** | [2.3 (4 ratings)](https://appshunter.io/ios/app/anticoagulation-manager/id1349838916/reviews) |
| Number of ratings | 3 | **4** |
| Positive reviews | 30.0% of reviews | **50.0% of reviews** |
| In-app purchases | No | No |
| Ads | No | No |
| Update frequency | **Every 7 months** | Every 13 months |
| Monetization | Free | Free |
| Size | 25 MB | 5 MB |
| Requires iOS | **11.0** | 12.0 |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Age rating | 17+ | 17+ |
| Developer | [American College of Cardiology](https://appshunter.io/developer/502174543) | [Centers For Disease Control and Prevention](https://appshunter.io/developer/439259253) |

## What reviewers say

### AnticoagEvaluator

[App page](https://appshunter.io/ios/app/anticoagevaluator/id609795286)

This medical app assists healthcare professionals in making informed decisions regarding antithrombotic therapy for patients with non-valvular atrial fibrillation. It calculates patient risk factors, provides guideline-driven therapy recommendations, and helps optimize anticoagulant dosages.

**Highlights:** Calculate renal function and stroke/bleed risk, Review ACC/AHA/HRS guideline therapy, Generate individualized antithrombotic risk, Optimize DOAC dosages, Based on SPARC Tool

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


### Anticoagulation Manager

[App page](https://appshunter.io/ios/app/anticoagulation-manager/id1349838916)

This medical app assists clinicians in determining the correct type and dose of anticoagulant drugs. It provides evidence-based, accessible, and accurate information for prescribing anticoagulants to manage abnormal clotting states.

**Highlights:** Anticoagulant drug selection, Laboratory testing guidance, Evidence-based clinical information, Management of abnormal clotting states, Prescribing support for clinicians

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


## Frequently asked questions

### Is AnticoagEvaluator free?

AnticoagEvaluator is free to download, with no in-app purchases.

### Is Anticoagulation Manager free?

Anticoagulation Manager is free to download, with no in-app purchases.

### Which has better reviews, AnticoagEvaluator or Anticoagulation Manager?

AnticoagEvaluator is rated higher. AnticoagEvaluator averages 2.3 out of 5 from 3 ratings, while Anticoagulation Manager averages 2.3 from 4 ratings.

### Do AnticoagEvaluator or Anticoagulation Manager have ads?

Neither AnticoagEvaluator nor Anticoagulation Manager shows ads.

### Which is updated more often, AnticoagEvaluator or Anticoagulation Manager?

AnticoagEvaluator ships an update every 7 months, and Anticoagulation Manager every 13 months. Most recently, AnticoagEvaluator was updated on November 5, 2026 and Anticoagulation Manager on November 5, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*
